Quick Takeaways
- Parag Mallick filed SCHEDULE 13D/A for Nautilus Biotechnology, Inc. Common stock, par value $0.0001 per share (NAUT).
- Disclosed ownership: 17%.
- Date of event: 03 Mar 2025.
Parag Mallick - 03 Mar 2025 SCHEDULE 13D/A Report for Nautilus Biotechnology, Inc. Common stock, par value $0.0001 per share (NAUT)
- Filing Manager
- Parag Mallick
- Reporting Manager
- Parag Mallick
- Symbol
- NAUT
- Shares outstanding
- 127,953,511 shares
- Disclosed Ownership
- 22,263,911 shares
- Ownership
- 17%
- Form type
- SCHEDULE 13D/A
- Filing time
- 05 Mar 2025, 16:57:11 UTC
- Date of event
- 03 Mar 2025
- Next filing
- 04 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Parag Mallick disclosed 17% ownership in Nautilus Biotechnology, Inc. Common stock, par value $0.0001 per share (NAUT) on 03 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Mar 2025, 16:57.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Parag Mallick | 17% | 22,263,911 | 22,063,911 | 200,000 | /s/ Matthew Murphy | Matthew Murphy/Attorney-in-fact | 0001857948 |